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B A C K G R O U N D
Technological features of CSII therapy comprise temporal basal 
rates, different basal rate profiles, use of bolus calculators, and 
bolus variants. In addition, real-time CGM data as well as compu-
terized analysis of glucose data can be used to adjust insulin pump 
therapy. In this study, the associations between the frequency of 
use of these technological features and glycaemic control were 
analysed.
M E T H O D S
Stepwise linear regression analysis with HbA1c as dependent va-
riable was performed. Independent variables were the frequen-
cy of use of the technological features mentioned above. 
Patients indicated the frequency of use per week of those fea-
tures on a five-point Likert scale (0-not at all, 1-less than once per 
week, 2-at least once a week, 3-several times per week, 4-daily).
R E S U L T S
264 patients participated in the study:
• Sample characteristics see table 1.
• The frequency of the use of different technological features
of CSII Treatment is depected in figure 1.
• The most frequent features used was the bolus calculator,
followed by the use of bolus options and temporary basal
rate. In univariate analysis significant associations between
glycaemic control and use of technological features were
detected for the frequency of temporal basal rates, bolus
options and computerized evaluations of SMBG/CGM Data
(see figures 2-4).
• In multivariate analysis (stepweise regression only use of
basal rate profiles as well as computerized analysis of glu-
cose as significant predictors of glycaemic control (β=-0.17,
p=.04; β=-0.20, p=.02).
D I S C U S S I O N
Patients used the technological features of their insulin pump 
rather rarely, in spite of a long duration of CSII treatment. More 
frequent use of different basal rate profiles and systematic ana-
lysis of glucose profiles were associated with better glycaemic 
control. 
Patients should be better educated how to interpret their glucose 
data and make use of the benefits of the technological features 
of their insulin pump.
Table 1:    Sample Characteristics
Figure 1:  Frequency of use of CSII technological features
Figure 2:  Impact of frequency of temporal basal rate per week on HbA1c
Figure 3: Impact of frequency of bolus options per week action on HbA1c
Figure 4:  Impact of frequency of computerized SMBG or CGM evaluation 
on HbA1c
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